Clinical Trial Update: Biomarker Study of Blood Samples From Patients With Non-Small Cell Lung Cancer Treated With Carboplatin and Paclitaxel With or Without Bevacizumab

View source ↗

Summary

A completed clinical trial biomarker study analyzing blood samples from patients with non-small cell lung cancer treated with carboplatin and paclitaxel, with o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: ECOG-ACRIN Cancer Research Group | Conditions: Lung Cancer | Status: COMPLETED